Global Cardiac Pacemakers Market 2017-2021: Key Vendors are Abbott, Biotronik, Boston Scientific & Medtronic

DUBLIN, September 6, 2017 /PRNewswire/ --

The "Global Cardiac Pacemakers Market 2017-2021" report has been added to Research and Markets' offering.

The global cardiac pacemakers market is forecast to grow at a CAGR of 12.90% during the period 2017-2021.

The report, Global Cardiac Pacemakers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is focus on new product launches. Development of new technologies in pacemakers by the leading manufacturers has positively impacted the output of the device. For instance, Medtronic developed leadless pacemaker, which was approved by the US FDA, is a revolutionary breakthrough in the pacemakers technology as leads were extensively used as a component of pacemaker over the several years.

According to the report, one driver in the market is decline in the prices of pacemakers. Medical device industry has been a profitable market for the manufacturers over the years as the cost of healthcare services are increasing drastically by every passing year. For instance, the US healthcare cost is increasing at a very high speed. However, the prices of medical devices like pacemakers have been dropping. The global cardiac pacemakers market is experiencing intense competition among the key manufacturers and local/regional players. The market is dominated by prominent players like Medtronic, St. Jude Medical, and Boston Scientific; however, the market is open for local players to hold larger share in the global market through breakthrough innovations.

Further, the report states that one challenge in the market is high competition from substitutes. There is an intensive competition from substitutes like medications, cardiac catheter ablation, and ICD. The ICD device is used when the heart muscle is weakened, and fast heartbeat interrupts individual's health condition negatively. Cardiac catheter ablation is performed using radiofrequency (which uses heat energy) or cryoablation (which uses cold temperature). It is implemented depending on the type of abnormal heart rhythm. The medications like antiarrhythmic drugs are used to treat abnormal heartbeat caused due to the irregular electrical activity of the heart.

Key vendors

• Abbott
• BIOTRONIK
• Boston Scientific
• Medtronic

Other prominent vendors

• Cardiac Science (a subsidiary of Quinton Cardiology)
• CCC Medical Devices
• Cook Medical
• GE Healthcare (a subsidiary of General Electric Company
• Others
  

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By Technology

Part 08: Market Segmentation By End-Users

Part 09: Geographical Segmentation

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Key Vendor Analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/trdr3s/global_cardiac

Media Contact:

Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]